130 related articles for article (PubMed ID: 38556691)
21. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck.
Fritsch VA; Cunningham JE; Lentsch EJ
Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717
[TBL] [Abstract][Full Text] [Related]
22. Nodal Basin Recurrence After Sentinel Lymph Node Biopsy for Melanoma: A Retrospective Multicenter Study in 2653 Patients.
Kretschmer L; Bertsch HP; Zapf A; Mitteldorf C; Satzger I; Thoms KM; Völker B; Schön MP; Gutzmer R; Starz H
Medicine (Baltimore); 2015 Sep; 94(36):e1433. PubMed ID: 26356697
[TBL] [Abstract][Full Text] [Related]
23. Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease.
Uppal A; Stern S; Thompson JF; Foshag L; Mizzollo N; Nieweg OE; Hoekstra HJ; Roses DF; Sondak VK; Kashani-Sabet M; Coventry BJ; Cochran AJ; Fujita M; Sim-Shin M; Elashoff D; Elashoff RM; Faries MB
Ann Surg Oncol; 2020 Jun; 27(6):1970-1977. PubMed ID: 31863416
[TBL] [Abstract][Full Text] [Related]
24. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
25. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse.
Govindarajan A; Ghazarian DM; McCready DR; Leong WL
Ann Surg Oncol; 2007 Feb; 14(2):906-12. PubMed ID: 17136471
[TBL] [Abstract][Full Text] [Related]
26. Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin.
Verver D; Madu MF; Oude Ophuis CMC; Faut M; de Wilt JHW; Bonenkamp JJ; Grünhagen DJ; van Akkooi ACJ; Verhoef C; van Leeuwen BL
Br J Surg; 2018 Jan; 105(1):96-105. PubMed ID: 29095479
[TBL] [Abstract][Full Text] [Related]
27. Does Stage Migration Occur as a Consequence of Omitting Completion Lymph Node Dissection for Melanoma?
Senders ZJ; Bartlett EK; Mouw TJ; McMasters KM; Egger ME
Ann Surg Oncol; 2023 Jun; 30(6):3648-3654. PubMed ID: 36934378
[TBL] [Abstract][Full Text] [Related]
28. Recurrence after sentinel lymph node biopsy in cutaneous melanoma: a single-center experience in Slovak patients.
Sabol M; Reken V; Sabolova L; Waczulikova I; Donat R; Dyttert D; Chvalny P; Durdik S
Neoplasma; 2019 Jul; 66(4):647-651. PubMed ID: 31058535
[TBL] [Abstract][Full Text] [Related]
29. Completion Lymph Node Dissection for Melanoma Before and After the Multicenter Selective Lymphadenectomy Trial-II in the United States.
Castle JT; Adatorwovor R; Levy BE; Marcinkowski EF; Merritt A; Stapleton JL; Burke EE
Ann Surg Oncol; 2023 Feb; 30(2):1184-1193. PubMed ID: 36331660
[TBL] [Abstract][Full Text] [Related]
30. Prevention of Secondary Lymphedema after Complete Lymph Node Dissection in Melanoma Patients: The Role of Preventive Multiple Lymphatic-Venous Anastomosis in Observational Era.
Nacchiero E; Maruccia M; Robusto F; Elia R; Di Cosmo A; Giudice G
Medicina (Kaunas); 2022 Jan; 58(1):. PubMed ID: 35056425
[No Abstract] [Full Text] [Related]
31. Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection.
Eroglu Z; Broman KK; Thompson JF; Nijhuis A; Hieken TJ; Kottschade L; Farma JM; Hotz M; Deneve J; Fleming M; Bartlett EK; Sharma A; Dossett L; Hughes T; Gyorki DE; Downs J; Karakousis G; Song Y; Lee A; Berman RS; van Akkooi A; Stahlie E; Han D; Vetto J; Beasley G; Farrow NE; Hui JYC; Moncrieff M; Nobes J; Baecher K; Perez M; Lowe M; Ollila DW; Collichio FA; Bagge RO; Mattsson J; Kroon HM; Chai H; Teras J; Sun J; Carr MJ; Tandon A; Babacan NA; Kim Y; Naqvi M; Zager J; Khushalani NI
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002183
[TBL] [Abstract][Full Text] [Related]
32. Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy.
Kingham TP; Panageas KS; Ariyan CE; Busam KJ; Brady MS; Coit DG
Ann Surg Oncol; 2010 Feb; 17(2):514-20. PubMed ID: 19924486
[TBL] [Abstract][Full Text] [Related]
33. Higher rates of regional disease but improved outcomes in pediatric versus adult melanoma.
Lautz TB; Fahy AS; Helenowski I; Wayne JD; Baertschiger RM; Aldrink JH
J Pediatr Surg; 2022 Oct; 57(10):425-429. PubMed ID: 34872730
[TBL] [Abstract][Full Text] [Related]
34. Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.
Masoud SJ; Perone JA; Farrow NE; Mosca PJ; Tyler DS; Beasley GM
Curr Treat Options Oncol; 2018 Sep; 19(11):55. PubMed ID: 30232648
[TBL] [Abstract][Full Text] [Related]
35. Completion lymphadenectomy for a positive sentinel node biopsy in melanoma patients is not associated with a survival benefit.
Klemen ND; Han G; Leong SP; Kashani-Sabet M; Vetto J; White R; Schneebaum S; Pockaj B; Mozzillo N; Charney K; Hoekstra H; Sondak VK; Messina JL; Zager JS; Han D
J Surg Oncol; 2019 Jun; 119(8):1053-1059. PubMed ID: 30883771
[TBL] [Abstract][Full Text] [Related]
36. Does the time interval between sentinel lymph node biopsy and completion lymph node dissection affect outcome in malignant melanoma? A retrospective cohort study.
Richtig G; Richtig E; Neiss AN; Quehenberger F; Gmainer DG; Kamolz LP; Lumenta DB
Int J Surg; 2020 Mar; 75():160-164. PubMed ID: 32036082
[TBL] [Abstract][Full Text] [Related]
37. Omission of Completion Lymph Node Dissection in Sentinel Node Biopsy Positive Head and Neck Cutaneous Melanoma Patients.
Kesmodel SB; Kronenfeld JP; Zhao W; Koru-Sengul T; Goel N; Weingrad DN; Hernandez-Aya L; Lutzky J; Feun L; Garland-Kledzik M; Crystal JS
Ann Surg Oncol; 2023 Nov; 30(12):7671-7685. PubMed ID: 37639029
[TBL] [Abstract][Full Text] [Related]
38. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
[TBL] [Abstract][Full Text] [Related]
39. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma.
de Vries M; Vonkeman WG; van Ginkel RJ; Hoekstra HJ
Eur J Surg Oncol; 2006 Sep; 32(7):785-9. PubMed ID: 16806794
[TBL] [Abstract][Full Text] [Related]
40. Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection.
van der Ploeg AP; van Akkooi AC; Rutkowski P; Cook M; Nieweg OE; Rossi CR; Testori A; Suciu S; Verhoef C; Eggermont AM;
Br J Surg; 2012 Oct; 99(10):1396-405. PubMed ID: 22961519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
